|
Market Closed -
Swiss Exchange
16:31:55 27/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 72.20 CHF | +4.79% |
|
+6.96% | +31.99% |
| 10-27 | Basilea Pharmaceutica Lifts FY26 Guidance | MT |
| 10-27 | Basilea raises full-year guidance 2026 and financial target for "Agenda 2030" and provides updates on late-stage clinical programs | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.08B | |||||
| 63.48B | |||||
| 54.55B | |||||
| 53.59B | |||||
| 44.75B | |||||
| 41.62B |
Select your edition
All financial news and data tailored to specific country editions
